Últimas noticias sobre Couchbase (NASDAQ:BASE) Bolsa

Couchbase

Couchbase Inc provides a modern cloud database that offers the robust capabilities required for business-critical applications on a scalable and available platform. It empower developers and architects to build, deploy and run mission-critical applications. Couchbase delivers a high-performance, flexible and scalable modern database that runs across the data center and any cloud. Geographically, the company generates a majority of its revenue from the United States.

Couchbase Inc

BASE Inc

Base Carbon Inc

Base Resources Ltd

Basel Medical Group Ltd

BASELLANDSCHAFTLICHE KANT by Basellandschaftliche Kantanalbank

Basellandschaftliche Kantonalbank

BASELODE ENERGY CORP by BASELODE ENERGY CORP.

Baselode Energy Corp

Canaccord Genuity analyst Maria Ripps maintains Spotify Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>) with a Buy and raises the price target from $475 to $525.

News

Price Target

Analyst Ratings

SPOT

Canaccord Genuity Maintains Buy on Spotify Technology, Raises Price Target to $525

CPRI

Capri CEO Says Co Is Well Positioned To Move Ahead As An Independent Public Company; Michael Kors Sales Impacted By Slowdown In Luxury Fashion Goods Globally And Outsized Weakness In China; Says Michael Kors Brand Was Not Evolving As Needed

Goldman Sachs analyst Ben Miller maintains Genius Sports (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GENI#NYSE">GENI</a>) with a Buy and raises the price target from $8.5 to $11.5.

GENI

Goldman Sachs Maintains Buy on Genius Sports, Raises Price Target to $11.5

Canaccord Genuity analyst Whitney Ijem maintains Passage Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PASG#NASDAQ">PASG</a>) with a Buy and maintains $13 price target.

PASG

Canaccord Genuity Maintains Buy on Passage Bio, Maintains $13 Price Target

Goldman Sachs analyst Eric Sheridan maintains Chegg (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHGG#NYSE">CHGG</a>) with a Neutral and lowers the price target from $3.75 to $1.75.

CHGG

Goldman Sachs Maintains Neutral on Chegg, Lowers Price Target to $1.75

RBC Capital analyst Pammi Bir reiterates Plaza Retail REIT (TSX:<a class="ticker" href="https://www.benzinga.com/stock/PLZ#TSX">PLZ</a>) with a Sector Perform and maintains C$4 price target.

Reiteration

TSX:PLZ

TSX:PLZ/UN

RBC Capital Reiterates Sector Perform on Plaza Retail REIT, Maintains C$4 Price Target

Canaccord Genuity analyst John Newman maintains Seres Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCRB#NASDAQ">MCRB</a>) with a Buy and maintains $10 price target.

MCRB

Canaccord Genuity Maintains Buy on Seres Therapeutics, Maintains $10 Price Target

Goldman Sachs analyst Eric Sheridan downgrades Angi (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANGI#NASDAQ">ANGI</a>) from Buy to Neutral and lowers the price target from $3.25 to $2.5.

Downgrades

ANGI

Goldman Sachs Downgrades Angi to Neutral, Lowers Price Target to $2.5

Trading Ideas

MTEM

Molecular Templates Shares Resume Trade Following Circuit Breaker Halt

ASML Holding NV (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>) shared its strategic roadmap during the 2024 Investor Day, highlighting key growth drivers and market expectations through <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/g41962514/asml-provides-updated-view-on-market-opportunities-at-2024-investor-day-meeting" rel="noreferrer noopener">the decade&#8217;s end</a>.
The semiconductor equipment maker projected significant revenue expansion, with scenarios estimating annual sales of $46.51 billion &#8211; $63.43 billion (44 billion euros &#8211; 60 billion euros) by 2030, alongside a gross margin target of 56%-60%.
CEO Christophe Fouquet sees the company&#8217;s extended lithography portfolio and scalable EUV (Extreme Ultraviolet) technology as crucial assets in capturing the potential of these emerging opportunities.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/emerging-markets/24/11/41951575/taiwan-semi-boosts-advanced-chipmaking-with-record-euv-expansion-grabs-56-global-share" rel="noreferrer noopener">Taiwan Semi Boosts Advanced Chipmaking with Record EUV Expansion, Grabs 56% Global Share</a>
ASML expects robust demand from the semiconductor sector, with projected global sales surpassing $1 trillion by 2030.
This outlook translates to an annual market growth rate of around 9% from 2025 to 2030. The firm anticipates a double-digit CAGR for EUV lithography spending within the same period, focusing on advanced Logic and DRAM nodes.
According to ASML, the integration of AI across industries presents a substantial opportunity for semiconductor firms. The company plans to leverage its EUV capabilities to accommodate the rising need for high-performance chips used in AI applications.
The scalability of EUV technology allows for efficient multi-patterning, which ASML expects will drive greater customer adoption through cost-effective manufacturing processes.
ASML&#8217;s CFO, Roger Dassen, highlighted the company&#8217;s confidence in its financial targets, citing a strong pipeline of product demand and increasing lithography spending.
He restated the company&#8217;s capital allocation strategy, which includes substantial returns to shareholders through dividends and share buybacks.
The company is navigating geopolitical tensions between Washington and China as a U.S. ally.
ASML CEO Christophe Fouquet acknowledges <a target="_blank" href="https://www.benzinga.com/government/regulations/24/11/41876507/asmls-it-outage-affected-chipmaking-operations-worldwide" rel="noreferrer noopener">rising U.S. pressure</a> to restrict chip technology sales to China. Despite this, China remains ASML&#8217;s top market, primarily for sales of mature chips rather than the advanced AI semiconductors targeted by U.S. export restrictions.
ASML dominates the market for specialized lithography machines, essential for companies like Taiwan Semiconductor Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) in producing cutting-edge chips used in Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) smartphones and Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) AI processors.
Reports suggest that Taiwan Semiconductor plans to purchase advanced ASML lithography equipment by the end of the year, with each unit priced at $350 million.
Price Actions:&nbsp;ASML stock traded higher by 5.09% at $707.67 at the last check on Thursday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/24/11/41977961/mastercards-vision-no-more-passwords-or-card-numbers-by-2030" target="_blank" rel="noreferrer noopener">Mastercard&#8217;s 2030 Vision: A Future Without Passwords, Card Numbers</a></li>
</ul>
Photo via ASML

Tech

AAPL

ASML

NVDA

ASML Projects Revenue Surge to $63 Billion by 2030, Eyes AI and Chip Market Boom

Canaccord Genuity analyst Kyle Mikson maintains Lucid Diagnostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUCD#NASDAQ">LUCD</a>) with a Buy and maintains $3 price target.

LUCD

Canaccord Genuity Maintains Buy on Lucid Diagnostics, Maintains $3 Price Target

Canaccord Genuity analyst Caitlin Cronin maintains KORU Medical Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRMD#NASDAQ">KRMD</a>) with a Buy and raises the price target from $3 to $4.

KRMD

Canaccord Genuity Maintains Buy on KORU Medical Systems, Raises Price Target to $4

Macro Economic Events

Econ #s

Economics

USA Gasoline Inventories A Draw Of 4.407M Barrels Vs A Build Of 1.000M Barrels Est.; Build Of 0.412M Prior

BMO Capital analyst Tamy Chen maintains Martinrea International (TSX:<a class="ticker" href="https://www.benzinga.com/stock/MRE#TSX">MRE</a>) with a Outperform and lowers the price target from C$15 to C$13.

TSX:MRE

BMO Capital Maintains Outperform on Martinrea International, Lowers Price Target to C$13

EIA Weekly Distillates Stocks A Draw Of 1.394M Barrels Vs A Build Of 1.000M Barrels Est.; Build Of 2.947M Barrels Prior

Canaccord Genuity analyst Joseph Vafi maintains HIVE Digital Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIVE#NASDAQ">HIVE</a>) with a Buy and raises the price target from $6 to $7.

HIVE

Canaccord Genuity Maintains Buy on HIVE Digital Technologies, Raises Price Target to $7

USA Crude Oil Inventories A Build Of 2.089M Barrels Vs A Build Of 0.400M Barrels Est.; Build Of 2.149M Barrels Prior

RBC Capital analyst Greg Pardy maintains Suncor Energy (TSX:<a class="ticker" href="https://www.benzinga.com/stock/SU#TSX">SU</a>) with a Outperform and raises the price target from C$64 to C$66.

TSX:SU

RBC Capital Maintains Outperform on Suncor Energy, Raises Price Target to C$66

BMO Capital analyst Devin Dodge maintains Finning International (TSX:<a class="ticker" href="https://www.benzinga.com/stock/FTT#TSX">FTT</a>) with a Outperform and lowers the price target from C$50 to C$46.

TSX:FTT

BMO Capital Maintains Outperform on Finning International, Lowers Price Target to C$46

Canaccord Genuity analyst George Gianarikas maintains ESS Tech (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWH#NYSE">GWH</a>) with a Hold and maintains $8 price target.

Canaccord Genuity Maintains Hold on ESS Tech, Maintains $8 Price Target

Sanjit Singh, an analyst from Morgan Stanley, maintained the Hold rating on Couchbase (BASE – Research Report). The associated price target was low...

Cautious Optimism Amidst Couchbase's Mixed Performance and Steady FY25 Outlook

D.A. Davidson analyst Rudy Kessinger maintained a Buy rating on Couchbase (BASE – Research Report) today and set a price target of $25.00. The comp...

D.A. Davidson Reaffirms Their Buy Rating on Couchbase (BASE)

Couchbase: Stay Hold Rated Given Uncertain ARR Growth Outlook

Couchbase (BASE – Research Report) received a Buy rating and a $19.00 price target from Barclays analyst Raimo Lenschow today. The company's shares...

Positive Report for Couchbase (BASE) from Barclays

Elastic, Dynatrace, Couchbase upgraded after challenges: Barclays

Couchbase upgraded to Outperform on new product releases: Wedbush

It's no secret that tech stocks have been powering the market gains over the past few years, and software stocks were among the biggest drivers of ...

Time to Hit Buy on These 2 Software Stocks, Says Daniel Ives

Baron Discovery Fund Q3 2024 Shareholder Letter

Couchbase: Tremendous Salvage Value In This Discarded Database Play

Wedbush analyst Daniel Ives maintained a Buy rating on Couchbase (BASE – Research Report) today and set a price target of $26.00. The company's sha...

Wedbush Keeps Their Buy Rating on Couchbase (BASE)

AEIS

ASGN

AXON

BASE

BCAP

BROE

CDNA

CWAN

CYBR

DKNG

ESTC

EXAS

GTLS

GWRE

INDI

KTOS

LLYVA

LLYVB

LLYVK

NARI

NVMI

SITE

TEMP

VCYT

Press Releases

Couchbase Announces Date of First Quarter Fiscal 2025 Financial Results Conference Call

Couchbase Announces New Employee Inducement Grants

Earnings

Couchbase Announces First Quarter Fiscal 2025 Financial Results

Couchbase Announces Date of Second Quarter Fiscal 2025 Financial Results Conference Call

Couchbase to Present at Upcoming Investor Conferences

Couchbase Capella Advancements Fuel Development of Adaptive Applications; Unlock Greater DBaaS Access for Developers

Couchbase Announces Second Quarter Fiscal 2025 Financial Results

Couchbase Announces Date of Third Quarter Fiscal 2025 Financial Results Conference Call

Comments

Couchbase

Noticias

Últimas noticias sobre Couchbase (NASDAQ:BASE) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL